Deferasirox Tablet, For Suspension
Product Images NDC 0480-7013

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 0480-7013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Deferasirox Tabs Fos A207124 1)

FDA Label Image

Figure 1 (Deferasirox Tabs Fos A207124 2)

This text details the change in liver iron content (LIC) and serum ferritin levels in response to different doses of Deferasirox, a medication used to reduce iron overload in the body. The data includes measurements taken at different time points and provides information on the correlation between the Deferasirox dosage and the levels of LIC and serum ferritin.*

FDA Label Image

Label, 125 mg, 30s (Deferasirox Tabs Fos A207124 3)

FDA Label Image

Label, 250 mg, 30s (Deferasirox Tabs Fos A207124 4)

FDA Label Image

Label, 500 mg, 30s (Deferasirox Tabs Fos A207124 5)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.